Skip to main content
Signal8

Mymetics Corporation (MYMX)

Sector: Biotechnology

Industry: Biotechnology

Mymetics Corporation logo

Mymetics Corporation

OTC:MYMXHealthcare
Mkt Cap-
EV-
Float74K
O/S153K
Inst Own-
Net Cash/Sh-
Dilution
Historical Data
DateOpenHighLowCloseVolume
Nov 13, 20260.00030.00030.00030.0003100
Nov 12, 20260.00030.00030.00030.0003100
Nov 11, 20260.00030.00030.00030.0003100
Nov 10, 20260.00030.00030.00030.0003100
Nov 9, 20260.00030.00030.00030.0003100
Nov 6, 20260.00030.00030.00030.0003100
Nov 5, 20260.00030.00030.00030.0003100
Nov 4, 20260.00030.00030.00030.0003100
Nov 3, 20260.00030.00030.00030.0003100
Nov 2, 20260.00030.00030.00030.0003100
Oct 30, 20260.00030.00030.00030.0003100
Oct 29, 20260.00030.00030.00030.0003100
Oct 28, 20260.00030.00030.00030.0003100
Oct 27, 20260.00030.00030.00030.0003100
Oct 26, 20260.00030.00030.00030.0003100
Oct 23, 20260.00030.00030.00030.0003100
Oct 22, 20260.00030.00030.00030.0003100
Oct 21, 20260.00030.00030.00030.0003100
Oct 20, 20260.00030.00030.00030.0003100
Oct 19, 20260.00030.00030.00030.0003100
Analyst Coverage
No analyst coverage for this companyNo ratings, price targets, or covering firms on file.
About

Mymetics Corporation is a Swiss biotechnology company dedicated to the research and development of vaccines aimed at preventing infectious and debilitating diseases.

Its robust pipeline features several promising vaccine candidates, including those for HIV-1/AIDS, COVID-19, intranasal influenza, respiratory syncytial virus (RSV), malaria, and chikungunya.

The company actively collaborates with leading institutions such as the Texas Biomedical Research Institute, the PATH Malaria Vaccine Initiative, and the National Institute of Allergy and Infectious Diseases' Laboratory of Malaria Immunology and Vaccinology, focusing on the development and production of virosome-based vaccine formulations for a malaria transmission-blocking agent.

Additionally, Mymetics works with Sanofi Pasteur Biologics, LLC to assess the immunogenicity of influenza vaccines. Founded in 1990, the company was formerly known as ICHOR Corporation, adopting its current name in July 2001, and maintains its base of operations in Epalinges, Switzerland.

Key Metrics
Market Cap--
Enterprise Value--
P/E Ratio--
Est. Net Cash/Share--
Institutional Ownership--

based on 153,333 shares outstanding

SectorHealthcare
IndustryBiotechnology
ExchangeOTC
CountryCHCH
IPO Date-
Shares Outstanding153,333
Authorized Shares
Float73,585
52-Week Range
Volume
Average Daily Volume--

30d Avg

--

60d Avg

--

90d Avg

--

Earnings
Dividend History
No dividend history available